B
2563
vs
B
BLLN
Over the past 12 months, Beijing Biostar Pharmaceuticals Co Ltd has underperformed BLLN, delivering a return of -76% compared to the BLLN's 26% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd
HKEX:2563
|
3.75
HKD
|
|||||
|
B
|
BillionToOne Inc
NASDAQ:BLLN
|
80.83
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
2563, BLLN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd
Revenue
|
|||||||||||
|
B
|
BillionToOne Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
2563, BLLN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd
HKEX:2563
|
|||||||||
|
B
|
BillionToOne Inc
NASDAQ:BLLN
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Beijing Biostar Pharmaceuticals Co Ltd | ||||
|
B
|
BillionToOne Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
2563, BLLN
Performance By Year
2563, BLLN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| KR |
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
|
| US |
M
|
Metsera Inc
NASDAQ:MTSR
|
|
| CN |
T
|
TransThera Sciences (Nanjing) Inc
HKEX:2617
|
|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
|
| DE |
A
|
Anbio Biotechnology
NASDAQ:NNNN
|
|
| US |
|
Alumis Inc
NASDAQ:ALMS
|
|
| KR |
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
|
| US |
M
|
Maze Therapeutics Inc
NASDAQ:MAZE
|
|
| US |
|
Grail Inc
NASDAQ:GRAL
|
|
| IN |
O
|
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
|